Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003-2013.
about
A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, RussiaIncreased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs.Role of Disputed Mutations in the Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosis
P2860
Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003-2013.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical Impact on Tuberculosi ...... istance, California 2003-2013.
@en
Clinical Impact on Tuberculosi ...... istance, California 2003-2013.
@nl
type
label
Clinical Impact on Tuberculosi ...... istance, California 2003-2013.
@en
Clinical Impact on Tuberculosi ...... istance, California 2003-2013.
@nl
prefLabel
Clinical Impact on Tuberculosi ...... istance, California 2003-2013.
@en
Clinical Impact on Tuberculosi ...... istance, California 2003-2013.
@nl
P2093
P2860
P356
P1476
Clinical Impact on Tuberculosi ...... istance, California 2003-2013.
@en
P2093
Ed Desmond
Gisela Schecter
Neha S Shah
Pennan M Barry
S Y Grace Lin
Yi-Ning Cheng
P2860
P304
P356
10.1093/OFID/OFW150
P577
2016-08-24T00:00:00Z